ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population

Journal of Hypertension
Kimmo PorthanAntti M Jula

Abstract

Left ventricular hypertrophy (LVH) is a strong risk factor for cardiovascular events. ECG is the most widely used method for LVH detection. Despite the abundance of ECG LVH criteria, their prognostic values have been compared in only a few studies, and little has been known about how sex modifies the prognostic value of LVH. We assessed the relationship between ECG LVH and incident cardiovascular events in the general population. Several ECG LVH criteria were measured in 3059 women and 2456 men participating in the Health 2000 Study - a national general population survey. Association between ECG LVH and cardiovascular events were analyzed with Cox proportional-hazards models. ECG LVH was more prevalent in women than in men when measured with Cornell-based criteria, but less prevalent or nondifferent when measured with other criteria. The association between ECG LVH and events showed higher hazard ratios for women than in men. Sex × LVH interaction terms were statistically significant in part of the LVH criteria. In adjusted Cox models, Sokolow-Lyon voltage performed the best. The composite of Sokolow-Lyon voltage and Cornell voltage was statistically significantly associated with events in both sexes. Sex affects both the preva...Continue Reading

References

Feb 1, 1995·Journal of the American College of Cardiology·P M OkinP Kligfield
Oct 1, 1994·The American Journal of Cardiology·G SchillaciC Porcellati
Aug 1, 1993·The American Journal of Cardiology·H M KrumholzD Levy
Feb 14, 1998·Journal of the American College of Cardiology·P VerdecchiaC Porcellati
Nov 11, 1998·Journal of the American College of Cardiology·A W HaiderD Levy
Mar 7, 2001·American Heart Journal·B A VakiliR B Devereux
Apr 25, 2001·Journal of Human Hypertension·E KumpusaloJ Takala
Nov 1, 1950·American Heart Journal·J A SCHACKL N KATZ
Aug 9, 2005·American Heart Journal·Bill P HsiehVictor F Froelicher
Jun 30, 2007·European Heart Journal·Cynthia M WesterhoutUNKNOWN GUSTO IV ACS Investigators
May 5, 2009·Journal of Hypertension·Mika KastarinenJaakko Tuomilehto
Feb 22, 2012·European Journal of Preventive Cardiology·Markku MähönenVeikko Salomaa
Mar 24, 2012·Journal of Hypertension·Philippe GosseSunthareth Yeim
Mar 25, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Kumar NarayananSumeet S Chugh

❮ Previous
Next ❯

Citations

May 18, 2016·Annals of Medicine·Jouni K JohanssonAntti M Jula
Apr 13, 2018·Scientific Reports·M Yldau Van Der EndePim Van Der Harst
Mar 19, 2021·Acta Neurologica Scandinavica·Nina ZaproudinaMikko Kallela
Mar 25, 2021·Scientific Reports·M Yldau van der EndePim van der Harst

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

Magellan
SPSS
STATA

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.